Acrivon Therapeutics (ACRV) Accounts Payables (2021 - 2026)
Acrivon Therapeutics (ACRV) reported Accounts Payables of $861,000 for Q2 2026, down 26.0% from $1.16 million a year earlier and down 25.9% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Accounts Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics posted Accounts Payables of $2.28 million, up 200.4% from FY2024.
- Accounts Payables has a four-year compound annual growth rate of 24.0% (FY2021 to FY2025).
- By year, Accounts Payables came in at $758,000 in FY2024 (-85.0%), $5.05 million in FY2023 (+458.4%), $904,000 in FY2022 (-6.2%) and $964,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Accounts Payables since Q4 2024.
- Year over year, Accounts Payables gained in three of the last eight quarters, with growth averaging 7.4%.
- The high point for year-over-year Accounts Payables in five years was Q4 2023 (growth of 458.4%); the low point was Q4 2024 (a decline of 85.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.16 million (Q1 2026), $2.28 million (Q4 2025) and $996,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Acrivon Therapeutics | 87.84 Mn | 87.84 Mn | - | 861,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 861,000.00 |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 2.28 Mn |
| Sep 30, 2025 | 996,000.00 |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | 758,000.00 |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 904,000.00 |
| Sep 30, 2022 | 1.98 Mn |
| Dec 31, 2021 | 964,000.00 |
API Access
Acrivon Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();